Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01839682
Other study ID # Siegel-1
Secondary ID 00017253
Status Completed
Phase N/A
First received April 10, 2013
Last updated April 25, 2013
Start date June 2009
Est. completion date July 2011

Study information

Verified date April 2013
Source Cedars-Sinai Medical Center
Contact n/a
Is FDA regulated No
Health authority United States: Institutional Review Board
Study type Observational

Clinical Trial Summary

This post-market surveillance research project consists of data collection at specified time points using standard questionnaire instruments to compare pain level, mobility and function pre and post procedure using the D-Fine StabiliT® Vertebral Augmentation System and StabiliT® Bone Cement, an FDA approved product used in the standard treatment of vertebral compression fractures.


Description:

This is a single arm, post market surveillance pilot study of an FDA cleared product, to evaluate the procedural and clinical profile of an ultra high viscosity cement vertebral augmentation system for the treatment of vertebral compression vertebral fractures due to osteoporosis.

Twenty (20) consenting evaluable adult male and female patients between the ages of 50 and 90 who meet the inclusion criteria for the study and are treated using the D-Fine StabiliT® Vertebral Augmentation System and StabiliT® Bone Cement as part of their standard treatment for osteoporotic vertebral compression fractures will be enrolled in the study.

The participants will be followed after the procedure for 3 months by telephone and/or mailed questionnaire by an IRB certified member of the research team. Information collected will include the patient's ability to ambulate independently and activity level pre and post-treatment, decrease or increase in pain level compared to pre-treatment, and monitoring adverse events. Data will be collected at enrollment, procedure, discharge (or 1 day post procedure), 1 week, 1 month and 3 months post procedure using the Visual Analog Scale (VAS) for pain score, Oswestry Disability Index. Standard of care radiographs and MRI or CT/bone scan are evaluated by a board certified radiologist. The data collected will be compared to measure outcomes.


Recruitment information / eligibility

Status Completed
Enrollment 23
Est. completion date July 2011
Est. primary completion date May 2011
Accepts healthy volunteers No
Gender Both
Age group 50 Years to 90 Years
Eligibility Inclusion Criteria:

- Males and females 50-90 years of age

- Pain on palpation/percussion over fractured vertebral body at one to three levels that require treatment

- Compression fracture(s), T10 to L5, with bone marrow edema imaged by magnetic resonance imaging (MRI)

- Visual Analog Scale (VAS) for pain >4 on a scale of 0-10

- Oswestry score of at least a moderate disability (21-40%)

- No major surgery to the spine planned for at least 1 month following enrollment

- Life expectancy of > 6 months

- Patient has sufficient mental capacity to comply with the protocol requirements

- Availability for all study visits and phone calls

- Understands the potential risks and benefits of participating in the study and is willing to provide written informed consent.

- Vertebral compression fracture with 20-90% compression (compared to adjacent normal vertebral body)

- Fracture age < 6 months

- Signal on MRI or bone scan consistent with non-healed fracture

- Female subjects must either be no longer capable of reproduction or taking acceptable measures to prevent pregnancy during the study

- Subject must be willing and able to comply with specified follow-up evaluations

Exclusion Criteria:

- Primary tumors and spinal metastasis, myeloma, or lymphoma of the spine

- More than 90% compression of the vertebrae

- Level(s) above T10

- Pedicle fracture

- Neurologic deficit associated with the level(s) to be treated

- Kyphosis > 30°

- Translation > 4 mm

- Instability of posterior wall with symptomatic displacement of fragment into spinal canal or significant canal compromise

- Intercostal nerve compression

- Active systemic or local infection at the level(s) to be treated

- Myelopathy

- Uncontrolled coagulopathy

- Cannot temporarily discontinue anticoagulation therapy

- Known allergy to device materials / PMMA

- Radiculopathy

- Cord compression or canal compromise requiring surgery for decompression

- Fracture due to high energy trauma

- Severe cardiopulmonary deficiencies

- Vertebra-plana

- Disabling back pain secondary to another cause that may interfere with accurate data collection

- Subjects who are known to be pregnant (pregnancy test required within10 days of treatment or lactating

- Females capable of reproduction and will not take acceptable measures to prevent reproduction during the study

- Currently enrolled in an investigational device (IDE) that has not completed the protocol required primary follow-up period (excludes 15 year follow-up of gene therapy trials)

- Lesions involving the pedicle

Study Design

Observational Model: Case-Only, Time Perspective: Prospective


Locations

Country Name City State
United States Cedars-Sinai Medical Center Los Angeles California

Sponsors (2)

Lead Sponsor Collaborator
Cedars-Sinai Medical Center DFINE Inc.

Country where clinical trial is conducted

United States, 

References & Publications (2)

Chin DK, Park JY, Yoon YS, Kuh SU, Jin BH, Kim KS, Cho YE. Prevalence of osteoporosis in patients requiring spine surgery: incidence and significance of osteoporosis in spine disease. Osteoporos Int. 2007 Sep;18(9):1219-24. Epub 2007 Mar 27. — View Citation

Ledlie JT, Renfro MB. Kyphoplasty treatment of vertebral fractures: 2-year outcomes show sustained benefits. Spine (Phila Pa 1976). 2006 Jan 1;31(1):57-64. Erratum in: Spine. 2006 Jun 15;31(14):1635. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Measure changes in pain Pain will be assessed using the Visual Assessment Scale (VAS) at enrollment, and interval changes captured at discharge (or 1 day), 1 week, 1 month and 3 months post procedure. Pre and post procedure pain will be compared. Enrollment, discharge (or 1 day), 1 week, 1 month, 3 month post procedure No
Secondary Assess changes in mobility. Assess changes in mobility using the Oswestry Disability Index pre to capture interval changes at enrollment, and at 1 month and 3 months post procedure. Enrollment, 1 month and 3 months post procedure No
See also
  Status Clinical Trial Phase
Active, not recruiting NCT06287502 - Efficacy of Structured Exercise-Nutritional Intervention on Sarcopenia in Patients With Osteoporosis N/A
Completed NCT03822078 - Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Denosumab (AMG 162) in Japanese Postmenopausal Women Phase 1
Recruiting NCT05845021 - Surgeon-Initiated Bone Health Referral Pathway in Patients Undergoing Lower Extremity Arthroplasty N/A
Completed NCT00092066 - A Study to Evaluate the Safety, Tolerability, and Efficacy of an Investigational Drug and Dietary Supplement in Men and Postmenopausal Women With Osteoporosis (0217A-227) Phase 3
Recruiting NCT04754711 - Interest of Nutritional Care of Children With Sickle Cell Disease on Bone Mineral Density and Body Composition N/A
Completed NCT04736693 - Replication of the HORIZON Pivotal Fracture Trial in Healthcare Claims Data
Not yet recruiting NCT06431867 - Primary Care Management of Osteoporosis in Older Women
Completed NCT02922478 - Role of Comorbidities in Chronic Heart Failure Study
Recruiting NCT02635022 - Fragility Fracture Liaison Service and Anti-osteoporosis Medication Monitoring Service Study
Recruiting NCT02616627 - Association Between DXA Results and the Complications, Clinical Courses and Outcomes in Chronic Dialysis Patients
Active, not recruiting NCT02617303 - Prevention of Falls and Its Consequences in Elderly People N/A
Completed NCT02566655 - Clinical Trial of Intravenous Infusion of Fucosylated Bone Marrow Mesenchyme Cells in Patients With Osteoporosis Phase 1
Not yet recruiting NCT02223572 - Secondary Fracture Prevention in Patients Who Suffered From Osteoporotic Fracture N/A
Completed NCT02559648 - Denosumab vs Placebo in Patients With Thalassemia Major and Osteoporosis Phase 2
Completed NCT03420716 - Symbiotic Yogurt, Calcium Absorption and Bone Health in Young Adult Women N/A
Completed NCT02003716 - DeFRA Questionnaire as an Anamnestic Form N/A
Not yet recruiting NCT01854086 - Compliance and Persistence With Osteoporosis Treatment and Attitude Towards Future Therapy Among Post-menopausal Israeli Women During Drug Treatment or Drug Holiday N/A
Unknown status NCT01913834 - Nasally and sc Administered Teriparatide in Healthy Volunteers Phase 1
Completed NCT01694784 - Understanding and Discouraging Overuse of Potentially Harmful Screening Tests N/A
Completed NCT01401556 - C-STOP Fracture Trial N/A